About this Research Topic

Background

Precision oncology can be broadly defined as the use of data from laboratory testing to inform therapeutic decision making. Despite recent scientific advancements, clinical implementation of individualized treatment strategies based on molecular profiling and other clinical testing remains suboptimal. Accordingly, studies show that while a majority of oncologists accept that the field of precision oncology is an emerging part of the clinical environment, less than a third acknowledge that it is widely applied in the care of patients. Moreover, considering that the first tissue-agnostic drugs in oncology were FDA-approved in the late 2010s, the field of precision oncology will only continue to grow as more drugs are approved based on molecular profiling and laboratory testing results that are independent from tissue of origin. Through this Research Topic, the medical community will have a better understanding of the precision oncology research landscape and the data potentially impacting clinical efficacy/outcomes with immunotherapy-based treatment strategies, which could facilitate more widespread utilization in conventional care.

Challenges to clinical implementation of precision oncology-directed treatments include physician education and adoption, analysis and interpretation of overwhelming datasets/reports, clinical trial access, and unknown testing costs associated with insurance coverage/reimbursement. Through the publication of studies using predictive efficacy or diagnostics to inform treatment considerations, reports on novel tests and analytical approaches being developed, and review articles landscaping either strategies for best-practice implementation or clinically approved testing modalities available commercially, scientific discoveries in precision oncology may be more efficiently and optimally translated into clinical care. Consequently, the goal of this Research Topic is to capture a comprehensive collection of journal articles focused on immunotherapeutic applications in the field of precision oncology that will collectively provide high-quality clinical evidence or research data and summarize emerging or commercially available laboratory tests to facilitate broader future clinical utilization. The data, review articles, and reports will not only highlight the immediate impact precision oncology-directed treatment strategies can have on patient outcomes but will also show the underutilized potential that still remains to be leveraged clinically.

In order to accomplish the objectives outlined above, we are interested in Original Research articles that would generally be considered precision oncology research with a focus on immunotherapy-based treatment strategies. In addition, we are also interested in Review/Mini Review and Case Report articles. Examples of studies can include, but are not limited to the following:
• in vitro and in vivo preclinical data as well as clinical studies, including case studies
• in vitro or in vivo laboratory tests (both clinically approved and research use only)
• Cellular or molecular level testing
• Analysis/interrogation of DNA/RNA sequencing data by NGS to guide clinical treatments
• Drug sensitivity or resistance testing
• Testing via protein expression by mass spectrometry
• Tests evaluating the effects of epigenetic modifications
• Reviews of precision oncology testing modalities commercially available (both diagnostic and predictive of treatment response)
• Reviews outlining strategies for best-practice implementation of precision oncology-directed treatment strategies in clinical care

Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by robust and relevant validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this topic.



Dr. Nicholas Young is Senior Research Director at Private Health Management. Dr. Emanuel F. Petricoin is a consultant, shareholder, and chair of the scientific advisory board at Theralink Technologies, Inc; consultant, shareholder, and Chief Science Officer at Perthera, Inc; and consultant, shareholder, and serves on the board of directors at Ceres Nanosciences. Dr. Aharon Freud is a consultant with ImmuneBridge, Inc. and ImmunoVec, Inc. The other topic editors declare no competing interests with regard to the topic theme.

Keywords: Proteomics, precision oncology, immunotherapy, individualized patient treatment, tumor-agnostic clinical testing, molecular profiling, genomics, epigenomics, pan-omics, drug sensitivity testing, efficacy, clinical trials, predictive susceptibility testing, clinical diagnostics, CLIA tests in oncology, Next-generation Sequencing – NGS (DNAseq/RNAseq

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

• What is a Research Topic?

  Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

  Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

• Why does Frontiers publish Research Topics? 

  The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

  Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

• Why are Research Topics important for journals?

  As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

  A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

• How do we ensure the quality of articles within Research Topics?

  Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

  In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

• What are the benefits of publishing my article in a Research Topic?

  Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

  As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

  Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

   
• What types of articles can be published in a Research Topic?

  Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

  Check available article types here 

• Can I suggest a new Research Topic? 

  Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

  Suggest your topic here 

• Who leads a Research Topic? 

  A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

  The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

• What is the role of a topic editor?

  As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

   

  You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

• What support will I receive when editing a new Research Topic? 

  As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

• As a junior researcher, can I be involved in editing a Research Topic? 

  If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

• Can I get a certificate for editing a Research Topic?

  Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

• Who will I collaborate with?

  Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

• How long does it take to publish a Research Topic?

  As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

  Find out more about our Research Topics

• What fee support is available to authors publishing in a Research Topic?

  Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

  Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

• Will there be a printed version of my Research Topic?

  In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.